CorMedix
(NASDAQ) CRMD
CorMedix Financials at a Glance
Market Cap
$530.43M
Revenue (TTM)
$311.71M
Net Income (TTM)
$163.05M
EPS (TTM)
$1.98
P/E Ratio
3.38
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Price
$6.72
Volume
44,529
Open
$6.72
Price
$6.72
Volume
44,529
Open
$6.72
Previous Close
$6.72
Daily Range
$6.64 - $6.97
52-Week Range
$5.60 - $17.43
Dividend
$0.00
Beta (Volatility)
1.11 (Average)
Price
$6.72
Volume
44,529
Open
$6.72
Previous Close
$6.72
Daily Range
$6.64 - $6.97
52-Week Range
$5.60 - $17.43
CRMD News
CRMD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CorMedix
Industry
Pharmaceuticals
Sector
Health CareEmployees
191
CEO
Joseph Todisco, MBA
Website
www.cormedix.comHeadquarters
Berkeley Heights, NJ 07922, US
CRMD Financials
Key Financial Metrics (TTM)
Gross Margin
88%
Operating Margin
48%
Net Income Margin
52%
Return on Equity
67%
Return on Capital
23%
Return on Assets
20%
Earnings Yield
29.59%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$530.43M
Shares Outstanding
79.05M
Volume
44.53K
Short Interest
0.00%
Avg. Volume
2.52M
Financials (TTM)
Gross Profit
$275.75M
Operating Income
$150.14M
EBITDA
$165.13M
Operating Cash Flow
$175.05M
Capital Expenditure
$2.26M
Free Cash Flow
$172.79M
Cash & ST Invst.
$149.52M
Total Debt
$148.91M
CorMedix Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$128.62M
+312.1%
Gross Profit
$107.31M
+257.3%
Gross Margin
83.43%
N/A
Market Cap
$530.43M
N/A
Market Cap/Employee
$8.29M
N/A
Employees
64
N/A
Net Income
$14.02M
+4.1%
EBITDA
$66.48M
+388.5%
Quarterly Fundamentals
Net Cash
$605.00K
-98.8%
Accounts Receivable
$171.23M
+231.5%
Inventory
$29.72M
+291.0%
Long Term Debt
$147.47M
+42142.6%
Short Term Debt
$1.45M
+762.9%
Return on Assets
19.74%
N/A
Return on Invested Capital
23.03%
N/A
Free Cash Flow
$94.42M
+1778.7%
Operating Cash Flow
$94.46M
+1782.4%